JP2025508987A5 - - Google Patents
Info
- Publication number
- JP2025508987A5 JP2025508987A5 JP2024552447A JP2024552447A JP2025508987A5 JP 2025508987 A5 JP2025508987 A5 JP 2025508987A5 JP 2024552447 A JP2024552447 A JP 2024552447A JP 2024552447 A JP2024552447 A JP 2024552447A JP 2025508987 A5 JP2025508987 A5 JP 2025508987A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- domain
- fusion protein
- sequence
- raav
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316220P | 2022-03-03 | 2022-03-03 | |
| US63/316,220 | 2022-03-03 | ||
| US202263384196P | 2022-11-17 | 2022-11-17 | |
| US63/384,196 | 2022-11-17 | ||
| PCT/US2023/063687 WO2023168411A1 (en) | 2022-03-03 | 2023-03-03 | Aav vectors for delivery of glp-1 receptor agonist fusions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508987A JP2025508987A (ja) | 2025-04-10 |
| JP2025508987A5 true JP2025508987A5 (enExample) | 2026-03-11 |
Family
ID=87884268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552447A Pending JP2025508987A (ja) | 2022-03-03 | 2023-03-03 | Ｇｌｐ－１受容体アゴニスト融合物の送達のためのａａｖベクター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250171515A1 (enExample) |
| EP (1) | EP4489770A4 (enExample) |
| JP (1) | JP2025508987A (enExample) |
| KR (1) | KR20240158267A (enExample) |
| CN (1) | CN119173269A (enExample) |
| AU (1) | AU2023227894A1 (enExample) |
| CA (1) | CA3245169A1 (enExample) |
| IL (1) | IL315256A (enExample) |
| MX (1) | MX2024010778A (enExample) |
| WO (1) | WO2023168411A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025230947A1 (en) * | 2024-04-30 | 2025-11-06 | Satellite Biosciences, Inc. | Engineered hepatocytes for secreting polypeptides |
| CN119351440B (zh) * | 2024-12-25 | 2025-04-25 | 浙江大学衢州研究院 | 表达glp-1的重组载体、重组酵母及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017024198A1 (en) * | 2015-08-06 | 2017-02-09 | The Trustees Of The University Of Pennsylvania | Glp-1 and use thereof in compositions for treating metabolic diseases |
| CN110964116A (zh) * | 2018-09-26 | 2020-04-07 | 北京辅仁瑞辉生物医药研究院有限公司 | GLP1-Fc融合蛋白及其缀合物 |
| HUE072201T2 (hu) * | 2019-08-08 | 2025-10-28 | Alexion Pharma Inc | Készítmények és eljárások az XA faktor és származékai elõállítására |
| TWI889865B (zh) * | 2020-07-10 | 2025-07-11 | 南韓商Ｇｉ醫諾微新股份有限公司 | 包含類升糖素胜肽-1及介白素-1受體拮抗物的融合蛋白及其用途 |
| WO2022036220A1 (en) * | 2020-08-14 | 2022-02-17 | The Trustees Of The University Of Pennsylvania | Novel aav capsids and compositions containing same |
| US20230372539A1 (en) * | 2020-08-24 | 2023-11-23 | The Trustees Of The University Of Pennsylvania | Viral vectors encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases |
-
2023
- 2023-03-03 US US18/843,440 patent/US20250171515A1/en active Pending
- 2023-03-03 CA CA3245169A patent/CA3245169A1/en active Pending
- 2023-03-03 AU AU2023227894A patent/AU2023227894A1/en active Pending
- 2023-03-03 EP EP23764178.2A patent/EP4489770A4/en active Pending
- 2023-03-03 JP JP2024552447A patent/JP2025508987A/ja active Pending
- 2023-03-03 WO PCT/US2023/063687 patent/WO2023168411A1/en not_active Ceased
- 2023-03-03 CN CN202380038014.XA patent/CN119173269A/zh active Pending
- 2023-03-03 IL IL315256A patent/IL315256A/en unknown
- 2023-03-03 KR KR1020247031776A patent/KR20240158267A/ko active Pending
-
2024
- 2024-09-02 MX MX2024010778A patent/MX2024010778A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023543125A5 (enExample) | ||
| JP2024054426A5 (enExample) | ||
| JP2018537984A5 (enExample) | ||
| JP2022500066A5 (enExample) | ||
| JP2023544683A5 (enExample) | ||
| JP2022531861A5 (enExample) | ||
| WO1999058700A1 (en) | Multiviral compositions and uses thereof | |
| TW201629225A (zh) | 第九因子基因療法 | |
| WO2001036623A2 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
| JP2019502378A5 (enExample) | ||
| JP2023534037A5 (enExample) | ||
| RU2018125468A (ru) | Генная терапия офтальмологических нарушений | |
| TW202246501A (zh) | ＳＭＮ１和ｍｉＲ－２３ａ在治療脊髓性肌萎縮中的協同作用 | |
| JP2021507687A5 (enExample) | ||
| JP2022505877A5 (enExample) | ||
| JP2023536008A5 (enExample) | ||
| JP2025120285A5 (enExample) | ||
| JP2021508241A5 (enExample) | ||
| JP2019524090A5 (enExample) | ||
| CN115151647A (zh) | Dna扩增方法 | |
| JP2018509154A5 (enExample) | ||
| JP2025509193A5 (enExample) | ||
| JP2018526994A5 (enExample) | ||
| JP2021533801A5 (enExample) | ||
| CN101213305A (zh) | 转基因在哺乳动物中枢神经系统中的可调控型表达 |